Although we are making considerable progress in the fight against cancer, we still have a long way to go. Often, the best new information about cancer comes from animals participating in a clinical trial.
If you do not live in our region of the country, you could check with the Veterinary Cancer Society to learn about clinical trials in your area.
We are currently recruiting dogs with multicentric lymphoma for multiple ongoing clinical studies.
Learn more about our Canine B-cell Lymphoma Trial
Learn more about our Canine T-cell Lymphoma Trial
For dogs with urinary bladder cancer (TCC) affecting the bladder and/or urethra. The study is aimed at learning how the dog’s immune system can be stimulated to attack the cancer.
Learn more about our Canine Urinary Bladder Cancer Trial
The WCORC and Purdue Institute for Cancer Research have recently launched a research program in canine osteosarcoma to identify new, effective therapies in dogs that will improve cure rates for both dogs and humans with this cancer.
Our current focus is on collecting tumor tissues from dogs undergoing amputation to analyze them for susceptibility to novel drugs. A financial incentive of $500 per dog is available to help offset the cost of amputation to the owners of dogs contributing to this research.
We are excited to announce a new clinical trial for osteosarcoma that studies the clinical, molecular, and immune characterization of this tumor type. Eligible dogs must have a confirmed diagnosis, no evidence of metastasis, or spread, to other parts of the body, and recieved no prior treatment.
These pictures illustrate an external (Figure 1) and internal view (Figure 2) of an osteosarcoma bone tumor in a dog. These tumors can be extremely painful and amputation is often recommended to relieve discomfort. As the tumor becomes larger, the dog will be unable to walk on the affected limb.
